[Ribavirin as an antiviral agent: chemistry, molecular mechanism of action and possibilities of use (review)]. 1986

G A Galegov, and N D L'vov, and I G Petrova, and V L Florent'ev

UI MeSH Term Description Entries
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D009975 Orthomyxoviridae A family of RNA viruses causing INFLUENZA and other respiratory diseases. Orthomyxoviridae includes INFLUENZAVIRUS A; INFLUENZAVIRUS B; INFLUENZAVIRUS C; INFLUENZAVIRUS D; ISAVIRUS; and THOGOTOVIRUS. Influenza Viruses,Myxoviruses,Orthomyxoviruses,Influenza Virus,Myxovirus,Orthomyxovirus
D010849 Picornaviridae A family of small RNA viruses comprising some important pathogens of humans and animals. Transmission usually occurs mechanically. There are nine genera: APHTHOVIRUS; CARDIOVIRUS; ENTEROVIRUS; ERBOVIRUS; HEPATOVIRUS; KOBUVIRUS; PARECHOVIRUS; RHINOVIRUS; and TESCHOVIRUS. Avihepatovirus,Pasivirus,Picornaviruses,Rosavirus,Sapelovirus,Senecavirus,Sicinivirus,Tremovirus,Avihepatoviruses,Pasiviruses,Rosaviruses,Sapeloviruses,Senecaviruses,Siciniviruses,Tremoviruses
D011212 Poxviridae A family of double-stranded DNA viruses infecting mammals (including humans), birds and insects. There are two subfamilies: CHORDOPOXVIRINAE, poxviruses of vertebrates, and ENTOMOPOXVIRINAE, poxviruses of insects. Poxviruses
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral

Related Publications

G A Galegov, and N D L'vov, and I G Petrova, and V L Florent'ev
January 1979, Pharmacology & therapeutics,
G A Galegov, and N D L'vov, and I G Petrova, and V L Florent'ev
May 1988, American journal of diseases of children (1960),
G A Galegov, and N D L'vov, and I G Petrova, and V L Florent'ev
January 1988, Pediatric nursing,
G A Galegov, and N D L'vov, and I G Petrova, and V L Florent'ev
September 1963, Science (New York, N.Y.),
G A Galegov, and N D L'vov, and I G Petrova, and V L Florent'ev
April 1987, Medical hypotheses,
G A Galegov, and N D L'vov, and I G Petrova, and V L Florent'ev
October 1982, Infection and immunity,
G A Galegov, and N D L'vov, and I G Petrova, and V L Florent'ev
October 2020, Viruses,
G A Galegov, and N D L'vov, and I G Petrova, and V L Florent'ev
July 2004, Nihon rinsho. Japanese journal of clinical medicine,
G A Galegov, and N D L'vov, and I G Petrova, and V L Florent'ev
July 2022, PLoS pathogens,
G A Galegov, and N D L'vov, and I G Petrova, and V L Florent'ev
January 2006, Journal of biochemistry and molecular biology,
Copied contents to your clipboard!